Companion Animal Welfare

Dog Lymphoma Welfare and Treatment

Canine lymphoma is one of the most common cancers in dogs with treatment options that can extend quality life significantly.

Key Facts

Lymphoma accounts for approximately 7-24% of all canine cancers
Multi-agent CHOP chemotherapy achieves remission in 70-90% of cases
Median survival with CHOP chemotherapy is 12 months with 25% living over 2 years
Most dogs tolerate chemotherapy well with manageable side effects
Palliative steroid treatment extends comfortable life by weeks to months when chemo is declined

Welfare Considerations

Canine lymphoma welfare involves decisions about treatment intensity, tolerance and quality of life throughout the disease course. Most dogs undergoing chemotherapy maintain good quality of life and benefit from treatment. Early detection and prompt treatment initiation optimise welfare outcomes.

What You Can Do

Seek specialist oncology assessment promptly if lymphoma is diagnosed in your dog
Discuss expected quality of life during treatment honestly with your oncologist
Monitor closely for side effects and adjust treatment if quality of life is compromised